Neuroimmune Interactions In Functional And Organic Gastrointestinal Diseases
Funder
National Health and Medical Research Council
Funding Amount
$419,180.00
Summary
Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD) are chronic, incurable diseases of the lower gastrointestinal tract with unknown causes and poor treatment options. Both the immune and nervous systems are altered in GI disease, but have traditionally been studied in isolation. My research investigates how the neuro-immune axis is altered in these diseases, using animal models and human tissue samples to identify novel treatment options for these debilitating diseases.
REMEDYING THE NEGLECT OF THE MOST COMMON COMPLICATION OF INFLAMMATORY BOWEL DISEASE: INTESTINAL STRICTURES.
Funder
National Health and Medical Research Council
Funding Amount
$123,368.00
Summary
Inflammatory bowel disease is a significant cause of debility in the Australian community. Some patients develop narrowing of the bowel which can cause intestinal blockages and require surgery. My research in this area will identify predictors of severe disease, allowing doctors to individualise treatment plans for each patient. I will also work to determine the best model of medical treatment and investigate new techniques which have the potential to avoid surgery.
Stricture Definition And Treatment (STRIDENT) Studies: New Diagnostic And Treatment Modalities For Inflammatory Bowel Disease Strictures
Funder
National Health and Medical Research Council
Funding Amount
$124,676.00
Summary
Inflammatory bowel disease (IBD), which includes Crohn disease and Ulcerative colitis, is becoming increasingly common in Australia. IBD strictures, which are a narrowing of bowel wall as a result of inflammation, can cause obstruction or blockage of food and liquid contents in the bowel. This results in significant patient morbidity and disease burden. Our research will aim to characterise strictures in IBD and investigate novel medical treatments to significantly improve outcomes in IBD.
Clinical And Microbiological Studies Of Faecal Microbiota Transplantation In Ulcerative Colitis - A Phase II, Multicentre, Randomised Double Blind, Exploratory Proof Of Concept, Placebo Controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$140,949.00
Summary
Ulcerative Colitis (UC) is a chronic inflammatory condition affecting the large bowel. It is the result of a dysfunctional immune system that inappropriately targets and damages the colon. There is increasing evidence that gut bacteria play a crucial role in UC, possibly by stimulating inappropriate activation of immune cells. We believe that by "transplanting" the faeces (and thus gut microbes) of healthy individuals into the colon of UC patients, we may change the bacterial make up and correct ....Ulcerative Colitis (UC) is a chronic inflammatory condition affecting the large bowel. It is the result of a dysfunctional immune system that inappropriately targets and damages the colon. There is increasing evidence that gut bacteria play a crucial role in UC, possibly by stimulating inappropriate activation of immune cells. We believe that by "transplanting" the faeces (and thus gut microbes) of healthy individuals into the colon of UC patients, we may change the bacterial make up and correct the inappropriate immune system activation.Read moreRead less
Vagal Nerve Stimulation As A Novel Therapy In Inflammatory Bowel Disease
Funder
National Health and Medical Research Council
Funding Amount
$88,502.00
Summary
Inflammatory bowel disease (IBD) is common exerting a large personal and societal burden to the Australian population. Current medications used to treat IBD are expensive, have many side effects and at times require hospitalisation for their administration. We aim to develop the non invasive and inexpensive technique of vagal nerve stimulation as a novel treatment strategy for IBD.
Prof Kamm is a gastroenterologist interested in developing improved treatments for gastrointestinal and pelvic floor disorders, such as inflammatory bowel disease and functional disorders. He runs basic science, translational and clinical strands of research in parallel across the same areas of interest, developing new treatments that encompass physiological, pharmacological, surgical and psychological therapies.
Muc1 Regulation Of The NLRP3 Inflammasome In The Gastrointestinal Tract
Funder
National Health and Medical Research Council
Funding Amount
$444,351.00
Summary
The mucin Muc1 is an important part of the barrier against infection in the gut, and appears to protect against development of bacterial inflammatory disease. We have identified that Muc1 suppresses activation of the inflammasome (a mechanism by which pathogens cause inflammation). We will now examine how Muc1 does this and explore the importance of this effect on inflammatory disease in the intestine. This may identify novel approaches for protecting against gastric and colorectal cancer.
Proteomics And Confocal Endomicroscopy In The Evaluation Of Inflammatory Bowel Diseases.
Funder
National Health and Medical Research Council
Funding Amount
$436,096.00
Summary
Inflammatory bowel diseases (IBD) result in devastating consequences and affect more young Australians than epilepsy or road traffic accidents. Damaged bowel results in loss of the normal gut barrier and flora can enter the tissue and even the blood. This concept of the "leaky gut" has been previously difficult to demonstrate. This can now be seen and measured using two new technologies called proteomics and confocal endomicroscopy. These tests offer new avenues of research for the 61,000 Austra ....Inflammatory bowel diseases (IBD) result in devastating consequences and affect more young Australians than epilepsy or road traffic accidents. Damaged bowel results in loss of the normal gut barrier and flora can enter the tissue and even the blood. This concept of the "leaky gut" has been previously difficult to demonstrate. This can now be seen and measured using two new technologies called proteomics and confocal endomicroscopy. These tests offer new avenues of research for the 61,000 Australian sufferers of IBD.Read moreRead less
Is Leaky Gut A Precursor To Inflammatory Bowel Disease?
Funder
National Health and Medical Research Council
Funding Amount
$89,176.00
Summary
Inflammatory Bowel Diseases (IBD) are chronic idiopathic diseases, characterised by episodes of relapse and remission of intestinal inflammation. Whilst the exact cause remains unknown, there is mounting evidence that a defect exists in the gut lining protecting the body in patients who develop IBD allowing bacterial antigens to enter the body. We aim to use novel imaging combined with colonoscopy called confocal endomicroscopy to image the bowel lining at high power to demonstrate this defect.